AbCellera Biologics Inc. (ABCL) Net income 2019–2025
AbCellera Biologics Inc. (ABCL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$146.4MFY2025 · since FY2019: -$2.2M → -$146.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$146.4M | +10.1% |
| FY2024 | -$162.9M | -11.2% |
| FY2023 | -$146.4M | -192.4% |
| FY2022 | $158.5M | +3.3% |
| FY2021 | $153.5M | +29.1% |
| FY2020 | $118.9M | +5478.5% |
| FY2019 | -$2.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice